Deltex Medical, an AIM listed firm which produces monitoring systems for post-operative patients, has fallen 9% this morning on news of restricted budgets in developed healthcare markets.
Europe's sovereign debt crisis has put significant pressure on government spending delaying or reducing expected sales of Deltex's equipment, which monitors blood flow to give doctors early warnings on a patient's condition.
Deltex saw a major order in the U.S. expected for the end of 2011 postponed into 2012.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
In the U.K the final nine months of the year were £200,000 behind the equivalent period of 2010.
Commenting on the results Deltex's Chairman Nigel Keen blamed the financial crisis for the company's difficulties: "Our revenue mix is being pushed from capital sales towards higher proportions of higher quality recurring revenue streams: we believe we have now absorbed the worst of the ensuing short term revenue loss from this transition."
Over the last 12 months Deltex is still up 19%.
-
Will a Santa Rally bring festive cheer to investor portfolios this year?Investors will be hoping for a seasonal stock market boost in December
-
ChatGPT turns two: how has it impacted markets?Two years on from ChatGPT’s explosive launch into the public sphere, we assess the impact that it has had on stock markets and the world of technology
